BioSpace News Archive

Press Releases

Medera Announces First Patient Dosed in Phase 2 Portion of MUSIC-HFrEF Phase 1b/2 Trial Evaluating SRD-001 Gene Therapy for Heart Failure with Reduced Ejection Fraction

October 28, 2025
·
4 min read
Press Releases

Apyx Medical Corporation to Participate in Upcoming November 2025 Investor Conferences

October 28, 2025
·
1 min read
Press Releases

TREMFYA® (guselkumab), the first and only IL-23 inhibitor with a fully subcutaneous treatment regimen, demonstrates durable remission in Crohn’s disease at two years

October 28, 2025
·
22 min read
Press Releases

Icotrokinra maintains standout combination of therapeutic benefit and a favorable safety profile in once-daily pill through 28 weeks in ulcerative colitis

October 28, 2025
·
11 min read
Press Releases

Amneal Launches Brekiya® – the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches

October 28, 2025
·
9 min read
Press Releases

Evaxion appoints Dr Helen Tayton-Martin as new Chief Executive Officer

October 28, 2025
·
6 min read
Press Releases

OXB to participate in upcoming November 2025 investor conferences and events

October 28, 2025
·
2 min read
Press Releases

Inspire Medical Systems, Inc. to Present at the 2025 UBS Global Healthcare Conference

October 28, 2025
·
1 min read
Press Releases

Hengrui Pharma Reports Steady Growth in Q3 2025 Driven by Innovation and Global Expansion

October 28, 2025
·
1 min read
Press Releases

Protagonist Announces New Icotrokinra Data in Ulcerative Colitis and Plaque Psoriasis Presented at Two Recent Medical Conferences

October 28, 2025
·
13 min read